← Back to Search

Exercise and Nutritional Counseling for Pancreatic Cancer

N/A

Waitlist Available

Led By Elizabeth Hile, PhD, PT

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Able to rise from a chair and walk household distances without assist from another person.

Age >30.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 year

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing if a pre-surgery exercise and diet program can improve outcomes for pancreatic cancer patients.

Who is the study for?

This trial is for individuals over 30 with suspected pancreatic or related tumors who are fit to exercise and can understand English. They must be able to move without help, agree to random assignment in home-based exercise programs, and use protein supplements if needed. Those already on a substantial exercise or protein regimen may only join the observational part of the study.

What is being tested?

Participants will receive dietary counseling and engage in home exercises at high frequency before surgery for pancreatic cancer. The study tests two types of pre-surgery 'prehabilitation': standard vs enhanced (with resistance training) exercises, aiming to improve physical function and quality of life within 2-3 weeks.

What are the potential side effects?

While specific side effects aren't listed, potential risks include those generally associated with new exercise regimens such as muscle soreness, fatigue, or injury. Allergic reactions could occur from whey protein supplementation if not previously identified.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can walk around my house without help.

Select...

I am older than 30 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Accrual

Adherence

Retention

Secondary study objectives

Assessment of Symptoms

Change in Body Weight

Physical Performance

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard Exercise GroupExperimental Treatment2 Interventions

Patients receive a single instruction session with a physical therapist, for training in moderate intensity (using Rate of Perceived Exertion) exercise including cardiovascular endurance, flexibility, and AROM of upper and lower body. If no other preferred mode of endurance training, a home ergometer is provided for use with arms and/or legs.

Group II: Enhanced Exercise GroupExperimental Treatment2 Interventions

Patients receive a single instruction session with a physical therapist, for training in moderate intensity (using Rate of Perceived Exertion) exercise including cardiovascular endurance, flexibility, and resistance exercise for upper and lower body. If no other preferred mode of endurance training, a home ergometer is provided for use with arms and/or legs.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Standard Exercise

2013

N/A

~180

Nutritional Counseling

2016

Completed Phase 2

~560